| Repurposing of drugs as STAT3 inhibitors for cancer therapy PS Thilakasiri, RS Dmello, TL Nero, MW Parker, M Ernst, AL Chand Seminars in cancer biology 68, 31-46, 2021 | 90 | 2021 |
| STAT3 signaling in breast cancer: multicellular actions and therapeutic potential SQ To, RS Dmello, AK Richards, M Ernst, AL Chand Cancers 14 (2), 429, 2022 | 52 | 2022 |
| Evaluating the benefits of renin-angiotensin system inhibitors as cancer treatments MV Perini, RS Dmello, TL Nero, AL Chand Pharmacology & therapeutics 211, 107527, 2020 | 52 | 2020 |
| Therapeutic targeting of the tumour microenvironment in metastatic colorectal cancer RS Dmello, SQ To, AL Chand International journal of molecular sciences 22 (4), 2067, 2021 | 24 | 2021 |
| Combination of bazedoxifene with chemotherapy and SMAC-mimetics for the treatment of colorectal cancer RS Dmello, M Palmieri, PS Thilakasiri, L Doughty, TL Nero, AR Poh, ... Cell Death & Disease 15 (4), 255, 2024 | 3 | 2024 |
| Mechanisms of cellular crosstalk in the gastric tumor microenvironment are mediated by YAP1 and STAT3 P Thilakasiri, RN O’Keefe, SQ To, D Chisanga, MF Eissmann, ALE Carli, ... Life Science Alliance 7 (2), 2024 | 2 | 2024 |
| Discovering new treatments for colorectal cancer RS Dmello La Trobe, 2023 | | 2023 |
| Determining the effect of bazedoxifene in combination with chemotherapy on colon cancer cells RS Dmello, P Thilakasiri, B Duscio, I Poon, M Ernst, A Chand Cancer Research 81 (13_Supplement), 1069-1069, 2021 | | 2021 |
